Αρχειοθήκη ιστολογίου

Αναζήτηση αυτού του ιστολογίου

Δευτέρα 15 Φεβρουαρίου 2016

HIV counselling and testing practices for children seen in an urban emergency department of a tertiary referral hospital in Dar es Salaam, Tanzania: a retrospective cross-sectional study

Objectives

To describe the HIV counselling and testing practices for children presenting to an emergency department (ED) in a low-income country.

Setting

The ED of a large east African national referral hospital.

Participants

This retrospective review of all paediatric (<18 years old) ED visits in 2012 enrolled patients who had an HIV test ordered and excluded those without testing. Files were available for 5540/5774 (96%) eligible patients and 1632 (30%) were tested for HIV, median age 1.3 years (IQR 9 months to 4 years), 58% <18 months old and 61% male.

Primary and secondary outcome measures

The primary outcome measure was documentation of pretest and post-test counselling, or deferral of counselling, for children tested for HIV in the ED. Secondary measures included the overall rate of HIV testing, rate of counselling documented in the inpatient record when deferred in the ED, rate of counselling documented when testing was initiated by the inpatient service, rate of counselling documented by test result (positive vs negative) and the rate of referral to follow-up HIV care among patients testing positive.

Results

Of 418 patients tested in the ED, counselling, or deferral of counselling, was documented for 70 (17%). When deferred to the ward, subsequent counselling was documented for 15/42 (36%). Counselling was documented in 33% of patients testing positive versus 1.1% patients testing negative (OR 43 (95% CI 23 to 83). Of 199 patients who tested positive and survived to hospital discharge, 76 (38%) were referred for follow-up at the HIV clinic on discharge.

Conclusions

Physicians documented the provision, or deferral, of counselling for <20% of children tested for HIV in the ED. Counselling was much more likely to be documented when the test result was positive. Less than 40% of those testing positive were referred for follow-up care.



from #Medicine via ola Kala on Inoreader http://ift.tt/1PB9H1o
via IFTTT

The Box Plots Alternative for Visualizing Quantitative Data

Although bar charts are popular among researchers and are ubiquitous in quantitative software packages, they do not always provide the best visualization for a dataset. This column discusses a simple, alternative graphical method that is often underappreciated: the box plot, also known as the box-and-whisker plot. The basic elements of the box plot are presented, along with how to correctly interpret box plots, variations that are available to provide more information, and free online software that researchers can use to create box plots for publication.

from #Medicine via ola Kala on Inoreader http://ift.tt/1LqC7He
via IFTTT

Aqueous humor SIRT1 in cataract

Kondo A, Goto M, Mimura T, Matsubara M

from #Medicine via ola Kala on Inoreader http://ift.tt/1Vijxqo
via IFTTT

Vagus Nerve Stimulation For Tinnitus


People suffering from severe tinnitus have a hard time finding helpful therapies. Now, a new treatment using vagus nerve stimulation for tinnitus relief is showing promising results for many people with this frustrating and debilitating condition.

Tinnitus is a medical condition in which a person hears ringing, whooshing, or buzzing sounds inside their head and ears. Many people experience short episodes of tinnitus symptoms from time to time. People with bad cases of tinnitus hear these sounds all the time, causing severe distraction, discomfort, and annoyance.

The Wandering Vagus Nerve

The vagus nerve is actually a long pair of nerves wandering throughout the body. (The origin of the word vagus means wanderer.) Much of the work done by the vagus nerve involves sending messages from bodily organs to the brain, alerting the brain about what the body is experiencing.

The vagus nerve is part of the parasympathetic nervous system starting in the 10th cranial nerve in the spinal cord and extending to the heart, stomach and other organs, and into the brain. The parasympathetic nervous system is composed of the nerves and hormonal receptors which quiet the body down after 'fight or flight' messages from the sympathetic nervous system.

Artificial stimulation of the vagus nerve has been in use for many years by researchers and medical professionals as a treatment for severe epilepsy. Now, new technology has been developed for stimulating the vagus nerve for tinnitus treatment, and many tinnitus sufferers are finding help with this therapy.

How Vagus Nerve Stimulation for Tinnitus Works

This therapy for tinnitus works by implanting a small electrical stimulator into the patient's neck. The devise attaches to the vagus nerve close to the point where it enters the auditory cortex. The patient then puts on a set of headphones and listens to a series of tones specifically designed to train their brain to ignore the tinnitus frequencies.

During a session of using vagus nerve stimulation for tinnitus therapy, the patient hears frequencies above and below the frequency of the bothersome tinnitus tones. Over time, the person's brain learns to ignore the tinnitus sounds, restoring normal activity in the auditory cortex.

For many people using vagus nerve stimulation for tinnitus treatment, the bothersome tinnitus sounds go away or subside considerably for several weeks after a treatment session. The treatment can then be repeated as needed in the patient's home using headphones and the digital audio application.

Sources:
http://ift.tt/1oiFACz
http://ift.tt/1U4DPFF




from #Medicine via ola Kala on Inoreader http://ift.tt/1oiFACB
via IFTTT

The cost-utility of integrated cervical cancer prevention strategies in the Ontario setting – Can we do better?

Publication date: Available online 15 February 2016
Source:Vaccine
Author(s): Beate Sander, William W.L. Wong, Man Wah Yeung, Orges Ormanidhi, Karen Atkin, Joan Murphy, Murray Krahn, Shelley L. Deeks
IntroductionA universal, publicly funded, school-based human papillomavirus (HPV) vaccination program in grade eight girls was initiated in Ontario in 2007. We present a cost-utility analysis of integrated cervical cancer prevention programs from the healthcare payer perspective.MethodsOur analysis was based on linked HPV transmission and disease history models. We obtained data from the literature, provincial surveys and Ontario population-based linked health administrative datasets. We modeled combinations of vaccination and screening strategies. We considered vaccination based on the Ontario experience, as well as conservative and optimistic scenarios, varying coverage, vaccine effectiveness and duration of protection. We considered 900 screening scenarios (screening start age: 21–70 years, screening interval: 3–20 years; 1-year time steps). The current schedule screens every 3 years starting at age 21 years. We examined (1) first vaccinated cohort (low herd-immunity), and (2) steady state, i.e. all cohorts were vaccinated (high herd-immunity).ResultsAdding vaccination to the current screening schedule was cost-effective (<C$10,000/quality-adjusted life year (QALY)) across all scenarios. Delaying screening start and/or extending screening intervals increased both expected QALYs and cost, and increased overall NHB for screening schedules with a start age of 25–35 years and 3–10-year intervals for most scenarios.ConclusionDelaying screening start age and/or extending screening intervals in vaccinated cohorts is likely to be cost-effective. Consideration should be given to both the short- and long-term implications of health policy decisions, particularly for infectious disease interventions that require long time intervals to reach steady state.



from #Medicine via ola Kala on Inoreader http://ift.tt/1U4DRgI
via IFTTT

Trends in differences between births and surviving infants reported for immunization program planning and external data sources in Eastern and Southern Africa 2000–2013

1-s2.0-S0264410X16X00084-cov150h.gif

Publication date: 24 February 2016
Source:Vaccine, Volume 34, Issue 9
Author(s): Reinhard Kaiser, Jethro M. Chakauya, Messeret E. Shibeshi
To inform our WHO team's support for immunization programs in Member States in Eastern and Southern Africa, we compared annual trends from 2000 to 2013 in target populations reported by Member States through the WHO-UNICEF joint reporting form with United Nations (UN) population projections and modeled infant mortality estimates from the UN Inter-agency Group for Child Mortality Estimation. Our findings indicated a tendency of underestimating births and surviving infants used by Member States as denominators for administrative immunization coverage rates, resulting in or contributing to overestimation of coverage. The difference with UN estimates appeared to be more pronounced for surviving infants than births. Measures of central tendency for individual country differences indicated that those differences decreased over time. Comparing trends of births and surviving infants with external sources can help monitoring progress in efforts to provide accurate and reliable target population estimates and sampling frames.



from #Medicine via ola Kala on Inoreader http://ift.tt/1oiFxGV
via IFTTT

Editorial Board/Aims and Scope

alertIcon.gif

Publication date: 24 February 2016
Source:Vaccine, Volume 34, Issue 9





from #Medicine via ola Kala on Inoreader http://ift.tt/1U4DRgy
via IFTTT